These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 38000306

  • 1. Loss of B1 and marginal zone B cells during ovarian cancer.
    Maslanka J, Torres G, Londregan J, Goldman N, Silberman D, Somerville J, Riggs JE.
    Cell Immunol; 2024; 395-396():104788. PubMed ID: 38000306
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
    Baert T, Vankerckhoven A, Riva M, Van Hoylandt A, Thirion G, Holger G, Mathivet T, Vergote I, Coosemans A.
    Front Immunol; 2019; 10():1273. PubMed ID: 31214202
    [Abstract] [Full Text] [Related]

  • 5. PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression.
    Prat M, Coulson K, Blot C, Jacquemin G, Romano M, Renoud ML, AlaEddine M, Le Naour A, Authier H, Rahabi MC, Benmoussa K, Salon M, Parny M, Delord JP, Ferron G, Lefèvre L, Couderc B, Coste A.
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586764
    [Abstract] [Full Text] [Related]

  • 6. The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia.
    Malkiel S, Kuhlow CJ, Mena P, Benach JL.
    J Immunol; 2009 Jan 01; 182(1):498-506. PubMed ID: 19109181
    [Abstract] [Full Text] [Related]

  • 7. Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk.
    Shea AA, Heffron CL, Grieco JP, Roberts PC, Schmelz EM.
    Front Immunol; 2023 Jan 01; 14():1323399. PubMed ID: 38264656
    [Abstract] [Full Text] [Related]

  • 8. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
    Yoshida M, Taguchi A, Kawana K, Ogishima J, Adachi K, Kawata A, Nakamura H, Sato M, Fujimoto A, Inoue T, Tomio K, Mori M, Nagamatsu T, Arimoto T, Koga K, Hiraike OW, Oda K, Kiyono T, Osuga Y, Fujii T.
    Int J Oncol; 2018 Oct 01; 53(4):1580-1590. PubMed ID: 30066851
    [Abstract] [Full Text] [Related]

  • 9. Human B1 Cells are the Main Blood Group A-Specific B Cells That Have a Moderate Correlation With Anti-A Antibody Titer.
    Xu Y, Lee JG, Yan JJ, Ryu JH, Xu S, Yang J.
    Ann Lab Med; 2020 Jan 01; 40(1):48-56. PubMed ID: 31432639
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A role for the nuclear receptor NR2F6 in peritoneal B cell homeostasis.
    Olson WJ, Jakic B, Labi V, Woelk J, Derudder E, Baier G, Hermann-Kleiter N.
    Front Immunol; 2022 Jan 01; 13():845235. PubMed ID: 36052079
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
    Lu L, Xu X, Zhang B, Zhang R, Ji H, Wang X.
    J Transl Med; 2014 Feb 07; 12():36. PubMed ID: 24502656
    [Abstract] [Full Text] [Related]

  • 14. Murine B1 B cells require IL-5 for optimal T cell-dependent activation.
    Erickson LD, Foy TM, Waldschmidt TJ.
    J Immunol; 2001 Feb 01; 166(3):1531-9. PubMed ID: 11160193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.
    Nagy JA, Herzberg KT, Masse EM, Zientara GP, Dvorak HF.
    Cancer Res; 1989 Oct 01; 49(19):5448-58. PubMed ID: 2475250
    [Abstract] [Full Text] [Related]

  • 19. Carboplatin and programmed death-ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID8 ovarian cancer model.
    Zhu X, Xu J, Cai H, Lang J.
    J Obstet Gynaecol Res; 2018 Feb 01; 44(2):303-311. PubMed ID: 29171115
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.